Rick Lesniewski
Impact in
-
- Protease and Inhibitor Mechanisms
- Oncology top 10%
- Peptidase Inhibition and Analysis
Papers in
-
- Angiogenesis and VEGF in Cancer 3
- Signaling Pathways in Disease 3
- Glycosylation and Glycoproteins Research 1
- Oncology 7
- Peptidase Inhibition and Analysis 4
- Lung Cancer Research Studies 1
- Co-authors
- Jack Henkin (3 shared papers)Pingping Lou (2 shared papers)Jieyi Wang (1 shared paper)Andrew J. Schneider (2 shared papers)David A. Egan (2 shared papers)Dimitri Semizarov (3 shared papers)Donald J. Davidson (2 shared papers)Catherine J. Haskell (1 shared paper)
- Journals
- Molecular Cancer Therapeutics (2 papers)Journal of Proteome Research (1 paper)Clinical Cancer Research (1 paper)European Journal of Cancer (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Rick Lesniewski
10 papers receiving 642 citations
Peers
Comparison fields: 5 of 81
- Cancer Research 132
- Oncology 235
- Cell Biology 124
- Molecular Biology 364
- Immunology and Allergy 18
Countries citing papers authored by Rick Lesniewski
This map shows the geographic impact of Rick Lesniewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Lesniewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Lesniewski more than expected).
Fields of papers citing papers by Rick Lesniewski
This network shows the impact of papers produced by Rick Lesniewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Lesniewski. The network helps show where Rick Lesniewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Rick Lesniewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 195 | |
| 2 | 2003 | 169 | |
| 3 | 2003 | 88 | |
| 4 | 2007 | 53 | |
| 5 | 2010 | 44 | |
| 6 | 2008 | 41 | |
| 7 | 2007 | 33 | |
| 8 | 2008 | 19 | |
| 9 | 2010 | 5 | |
| 10 | Characterization of human circulating endothelial cells to monitor response to antitumor therapy in human clinical trials | 2006 | 1 |
About Rick Lesniewski
Rick Lesniewski is a scholar working on Molecular Biology, Oncology, Cancer Research, Cellular and Molecular Neuroscience and Mechanics of Materials, having authored 10 papers that have together received 648 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Signaling Pathways in Disease (3 papers), Protease and Inhibitor Mechanisms (2 papers), Neuropeptides and Animal Physiology (2 papers), Metal and Thin Film Mechanics (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (132 citations), Oncology (235 citations), Cell Biology (124 citations), Molecular Biology (364 citations) and Immunology and Allergy (18 citations). Rick Lesniewski has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Jack Henkin, Pingping Lou, Jieyi Wang, Andrew J. Schneider, David A. Egan, Dimitri Semizarov, Donald J. Davidson, Catherine J. Haskell, Karl A. Walter and Zhebo Chen. Their work appears in journals such as Molecular Cancer Therapeutics, Journal of Proteome Research, Clinical Cancer Research, European Journal of Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.